Matt Jung- Right board
Download
Report
Transcript Matt Jung- Right board
Discussion
Supports Seeman’s studies 1975 in 2005.
Receptors expressed better with mutations in the first
protomer with beta gamma biosensor.
Receptors expressed better with mutations in the second
protomer with the Alpha biosensor.
Proteins and receptors may not have been transfected
properly.
Seeman P. et.al. PNAS 2005;102:3513-3518
Figure 10: Data table from Seaman's most recent study. He treated
D2 receptors with Olanzapine and observed an increase in the
amount of receptors in the D2 High states.
Conclusion
Receptors continued to express despite
inhibitons
Supports the Dopamine hypothesis of
Schizophrenia
Supports Seeman’s studies in 1975 and
2005
Future Research
Deletion in one of the
transmembrane receptors
FACS Assay
http://www.smbs.buffalo.edu/confocal/array.jpg
References
•1. Angers,S., Salahpour,A., Joly,E., Hilairet,S., Chelsky,D., Dennis,M., and Bouvier,M. (2000). Detection of
beta(2)-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).
Proceedings of the National Academy of Sciences of the United States of America, 97, 3684-3689.
•2. Ballesteros,J.A., Shi,L., and Javitch,J.A. (2001b). Structural mimicry in G protein-coupled receptors:
Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like
receptors. Mol Pharmacol, 60, 1-19
• 3. Baneres,J.L. and Parello,J. (2003b). Structure-based analysis of GPCR unction: Evidence for a novel
pentameric assembly between the dimeric leukotriene B-4 receptor BLT1 and the G-protein. Journal of Molecular
Biology, 329, 815-829.
•4. Bockaert,J. and Pin,J.P. (1999). Molecular tinkering of G protein-coupled receptors: an evolutionary success.
Embo Journal, 18, 1723-1729.
•5. Bouvier,M. (2001). Oligomerization of G-protein-coupled transmitter receptors. Nature Reviews Neuroscience,
2, 274-286.
•6. Elling,C.E., Nielsen,S.M., and Schwartz,T.W. (1995). Conversion of Antagonist-Binding Site to Metal-Ion Site in
the Tachykinin Nk-1 Receptor. Nature, 374, 74-77.
•7. Farrens,D.L., Altenbach,C., Yang,K., Hubbell,W.L., and Khorana,H.G. (1996). Requirement of rigid-body
motion of transmembrane helices for light activation of rhodopsin. Science, 274, 768-770.
• 8. Filipek,S., Stenkamp,R.E., Teller,D.C., and Palczewski,K. (2003). G protein-coupled receptor rhodopsin: A
prospectus. Annual Review of Physiology, 65, 851-879.
•9. Fredriksson,R., Lagerstrom,M.C., Lundin,L.G., and Schioth,H.B. (2003). The G-protein-coupled receptors in the
human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol,
63, 1256-1272.
•10. Fredriksson,R. and Schioth,H.B. (2005). The Repertoire of G-Protein-Coupled Receptors in Fully Sequenced
Genomes. Mol Pharmacol, 67, 1414-1425.
• 11. George,S.R., O'Dowd,B.F., and Lee,S.R. (2002). G-protein-coupled receptor oligomerization and its potential
for drug discovery. Nature Reviews Drug Discovery, 1, 808-820
• 12. Gether,U. (2000). Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.
Endocr Rev, 21, 90-113.
•13. Guo W., Urizar E, Kralikova M., Mobarec J.C., Shi L., Marta Filizola & Jonathan A Javitch (2008). Dopamine
D2 receptors form higher order oligomers at physiological expression levels. The EMBO Journal advance online
publication 31 July 2008; doi:10.1038/emboj.2008.153
• 14. Hoon, M.A., Adler,E., Lindemeier,J., Battey,J.F., Ryba,N.J.P., and Zuker,C.S. (1999). Putative mammalian
taste receptors: A class of taste-specific GPCRs with distinct topographic selectivity. Cell, 96, 541-551.
• 15. Bacart J., Corbel C., Jockers R., Bach S., Couturier C.. (2008) The BRET technology and its application to
screening assays. Biotechnology Journal 3:3, 311-324
•16. Jorm AF, Barney LJ, Christensen H, Highet NJ, Kelly CM, Kitch- ener BA: Research on mental health literacy:
what we know and what we still need to know. Aust N Z J Psychiatry 2006; 40: 3–5
•17. Kojouharova, Mihaela S., Gadjeva, Mihaela G., Tsacheva Ivanka G., Aleksandra Zlatarova, Liubka T.
Roumenina, Magdalena I. Tchorbadjieva, Boris P. Atanasov, Patrick Waters, Urban, B.C., Sim, Robert B., Reid,
K.B.M and Kishore, U. Mutational Analyses of the Recombinant Globular Regions of Human C1q A, B, and C
Chains Suggest an Essential Role for Arginine and Histidine Residues in the C1q-IgG Interaction1. The Journal of
Immunology, 2004, 172: 4351– 4358.
• 18. Kenakin,T. (2003). Ligand-selective receptor conformations revisited: the promise and the problem. Trends in
Pharmacological Sciences, 24, 346-354.
•19. Kristiansen,K. (2004). Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of Gprotein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Pharmacology & Therapeutics, 103, 21-80.
• 20. Luchins, D. (1975)The Dopamine Hypothesis of Schizophrenia A Critical Analysis. Neuropsychobiology ;1:365-378
•20. Maggio,R., Vogel,Z., and Wess,J. (1993). Coexpression Studies with Mutant Muscarinic Adrenergic-Receptors Provide
Evidence for Intermolecular Cross- Talk Between G-Protein-Linked Receptors. Proceedings of the National Academy of
Sciences of the United States of America, 90, 3103-3107.
• 22. Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S:Differential effects of aripiprazole on D2, 5-HT2, and
5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 2007; 164:1411–1417
• 23. Meng,E.C. and Bourne,H.R. (2001). Receptor activation: what does the rhodopsin structure tell us? Trends in
Pharmacological Sciences, 22, 587-593.
• 24. Neves SR, Ram PT, Iyengar R (May 2002). G protein pathways. Science (journal) 296 (5573): 1636–9.
•25. Ng, G.Y.K., O'Dowd, Brian F., Lee, Samuel P., Chung, Hans T., Brann, Mark R., Seeman, P. and George, Susan R.
Biochemical and Biophysical Research Communications, Volume 227, Issue 1, 3 October 1996, Pages 200-204
• 26. Palczewski,K., Kumasaka,T., Hori,T., Behnke,C.A., Motoshima,H., Fox,B.A., Le Trong,I., Teller,D.C., Okada,T.,
Stenkamp,R.E., Yamamoto,M., and Miyano,M. (2000). Crystal structure of rhodopsin: A G protein-coupled receptor.
Science, 289, 739-745.
• 27. Pauwels,P.J. and Wurch,T. (1998). Amino acid domains involved in constitutive activation of G-protein-coupled
receptors - Review. Molecular Neurobiology, 17, 109-135.
•28. Seeman P., Weinshenker D., Quirion R., Srivastava L.K., BhardwajS.K., Grandy D.K., Richard T. Premont, Tatyana D.
Sotnikova, Patricia Boksa, Mufida El-Ghundi, Brian F. O'dowd, Susan R. George, Melissa L. Perreault, Pekka T. Mannisto,
Siobhan Robinson, Richard D. Palmiter & Teresa Tallerico (March 2005). "Dopamine supersensitivity correlates with D2
High states, implying many paths to psychosis". Proceedings of the National Academy of Sciences of the United States of
America 102 (9): 3513–3518.
•29. Swaminath,G., Deupi,X., Lee,T.W., Zhu,W., Thian,F.S., Kobilka,T.S., and Kobilka,B. (2005). Probing the gamma2
adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J.
Biol. Chem., M502352200.
•30. Turner,J.H., Gelasco,A.K., and Raymond,J.R. (2004). Calmodulin interacts with the third intracellular loop of the
serotonin 5-hydroxytryptamine(1A) receptor at two distinct sites - Putative role in receptor phosphorylation by protein kinase
C. J. Biol. Chem., 279, 17027-17037.
•31. Wess,J. (1998). Molecular basis of receptor/G-protein-coupling selectivity. Pharmacology & Therapeutics, 80, 231-264.
•32. Wu,P.G. and Brand,L. (1994). Resonance Energy-Transfer - Methods and Applications. Analytical Biochemistry, 218, 113.